Search
Selected Filter
Filter Results
Displaying 1–10 of 239 diseases results
-
Feb 11, 2026
SparingVision Completes Dosing in Gene-Agnostic Therapy Trial for Retinitis Pigmentosa (RP)
Research NewsNovel neuroprotective approach could benefit RP patients regardless of genetic mutation
-
Feb 6, 2026
Eye on the Cure Podcast | Episode 99: Dr. Prem Subramanian
Eye on the CureDr. Subramanian discusses thyroid eye disease (TED), its potential causes, symptoms, and therapeutic approaches.
-
Jan 28, 2026
Research NewsMarking an important milestone for this rare form of retinitis pigmentosa (RP)
-
Jan 26, 2026
Story Update: Seeing Through Your Disability
Beacon StoriesLance Johnson shares life with retinitis pigmentosa (RP) as a creator, father, and Foundation Fighting Blindness ambassador—advocating for awareness and advancing treatments and cures.
-
Jan 16, 2026
AAVantgarde Completes Enrollment in Retinal Gene Therapy Trial for Usher Syndrome Type 1B
Research NewsMilestone brings hope to patients with rare inherited retinal disease
-
Jan 13, 2026
Research NewsFirst patient treated in Part B of ASTRA trial evaluating SB-007.
-
Jan 9, 2026
Eye on the Cure Podcast | Episode 98: Jonathan & Josh Steinberg
Eye on the CureJosh Steinberg and his father, Jon, talk with host Ben Shaberman about their close-knit family’s journey with Josh’s vision loss.
-
Dec 19, 2025
Eye on the Cure Podcast | Episode 97: Lindsey Rambo
Eye on the CureA mom, wife, and a special education teaching assistant, Lindsey is the first participant in a groundbreaking gene therapy trial for Leber congenital amaurosis (LCA5).
-
Dec 18, 2025
The Super-Sticky Shoes: Living With Retinitis Pigmentosa When the World Can’t See the Glue
Invisible DisabilityIn this deeply personal reflection, author Patti Brite Taylor shares what it feels like to live with retinitis pigmentosa—and how that experience inspired her mystery novel, The Vanishing Cactus, centered on a heroine with low vision.
-
Dec 18, 2025
Beacon Therapeutics Launches Clinical Trial for Bilateral Administration of XLRP Gene Therapy
Research NewsThe company has also fully enrolled the Phase 2/3 VISTA clinical trial for its XLRP gene therapy.